- /
- Supported exchanges
- / OL
- / EXTX.OL
Exact Therapeutics AS (EXTX OL) stock market data APIs
Exact Therapeutics AS Financial Data Overview
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy. The company's ACT platform is under Phase 2 clinical trial for the treatment of pancreatic disease; Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. It has a collaboration with GE Healthcare. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Exact Therapeutics AS data using free add-ons & libraries
Get Exact Therapeutics AS Fundamental Data
Exact Therapeutics AS Fundamental data includes:
- Net Revenue: 78 000
- EBITDA: -74 010 176
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Exact Therapeutics AS News
New
Panostaja Oyj And 2 Other European Penny Stocks To Watch
European markets have recently shown mixed performance, with the pan-European STOXX Europe 600 Index declining slightly as investors weigh geopolitical developments and economic data. In this context,...
Uncovering Hidden Gems: S.C. Ropharma And 2 Other European Penny Stocks
As the European market continues to thrive, with the STOXX Europe 600 Index reaching new highs and major indexes posting strong annual gains, investors are increasingly looking for opportunities in le...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.